Skip to main content
Clinical Trials/NCT05890833
NCT05890833
Recruiting
Not Applicable

The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders

LMU Klinikum1 site in 1 country30 target enrollmentSeptember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inclusion Body Myositis
Sponsor
LMU Klinikum
Enrollment
30
Locations
1
Primary Endpoint
FBIndex
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The combination of short quantitatively assessing muscular function and balance in combination with short clinical scores, can be a new valid approach to evaluate the patient risk of fall and help to create a quick checkup test to prescribe an appropriate assistive device.

The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with neuromuscular diseases (NMD) based on correlation between clinical assessments between two groups of NMD patients and scales used to assess risk of falling for patients.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
September 1, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
LMU Klinikum
Responsible Party
Principal Investigator
Principal Investigator

Marko Mijic

Master of Sports and Movement Therapy

LMU Klinikum

Eligibility Criteria

Inclusion Criteria

  • Patients between 18- and 65-year-old
  • Patients with adequate cognitive and communication function to fill out the scales assessing risk of falling
  • The neuromuscular disease needs to be confirmed by genetic report and/or disease deepening neurophysiological examination.

Exclusion Criteria

  • Patients which are not able to perform motoric functional assessments without assistive gait device.

Outcomes

Primary Outcomes

FBIndex

Time Frame: 2 years

The primary goal of this project is to provide a short battery of clinical assessments used to determine risk of falling for patients with NMDs based on correlation between clinical assessments: Heel-Rise-Test, Chair-Rise Test, Semi-tandem stand, Trunk Rise Test, and Foot-tapping speed, Timed Up and Go test, 10 Meter Walk Test and Six Minute Walk test, between two groups of NMD patients and scales: "The Falls Efficacy Scale International FES-I" and "The Morse Fall Scale" used to assess risk of falling for patients.

Study Sites (1)

Loading locations...

Similar Trials